Literature DB >> 18623133

Association study of CCR5 delta 32 polymorphism among the HLA-DRB1 Caucasian population in Northern Paraná, Brazil.

Sandra Marcia Muxel1, Sueli Donizete Borelli, Marla Karine Amarante, Julio Cesar Voltarelli, Mateus Nobrega Aoki, Carlos Eduardo Coral de Oliveira, Maria Angelica Ehara Watanabe.   

Abstract

Chemokines are important determinants of early inflammatory response. The CC chemokine receptor 5 (CCR5) delta 32 variant results in a nonfunctional form of the chemokine receptor and has been implicated in a variety of immune-mediated diseases. In the present study, polymerase chain reaction (PCR) for genomic deoxyribonucleic acid (DNA) samples, using specific CCR5 oligonucleotide primers surrounding the breakpoint deletion, detected a 225-basepair (bp) product from the normal CCR5 allele and a 193-bp product from the 32 bp deletion allele. Human leukocyte antigen (HLA) class II (DRB1) typing was performed by PCR-sequence-specific primer (PCR-SSP). The aim of this study was to evaluate the association of HLA-DRB1 and CCR5 genetic polymorphisms. To evaluate the frequency distributions of CCR5 delta 32 polymorphisms in a Brazilian population and their association with allelic distribution of HLA genes, DRB1; a total of 120 Caucasian individuals from northern Paraná, Brazil, were tested. The CCR5/CCR5 genotype was found in 108 individuals (90%) and only one carried the CCR5 delta 32 allele homozygous genotype (0.0238), while 12 (10%) carried the CCR5 delta 32 allele heterozygous genotype. The observed frequency for the CCR5 delta 32 allele was 0.05 in the population studied. The results revealed a CCR5 delta 32 allele occurrence with HLA-DRB1(*)01 and DRB1(*)04 (P<0.05). It is possible that HLA-DRB1(*)01 and DRB1(*)04 alleles could be associated with the delta 32-bp deletion of CCR5.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18623133      PMCID: PMC6648960          DOI: 10.1002/jcla.20225

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  33 in total

Review 1.  MHC superfamily structure and the immune system.

Authors:  K Maenaka; E Y Jones
Journal:  Curr Opin Struct Biol       Date:  1999-12       Impact factor: 6.809

2.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.

Authors:  M W Smith; M Dean; M Carrington; C Winkler; G A Huttley; D A Lomb; J J Goedert; T R O'Brien; L P Jacobson; R Kaslow; S Buchbinder; E Vittinghoff; D Vlahov; K Hoots; M W Hilgartner; S J O'Brien
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

3.  Distribution of CCR5-delta32, CCR2-64I, and SDF1-3'A mutations in populations from the Brazilian Amazon region.

Authors:  Fernanda Andreza De Pinho Lott Carvalhaes; Greice Lemos Cardoso; Igor Guerreiro Hamoy; Yan Tat Liu; João Farias Guerreiro
Journal:  Hum Biol       Date:  2004-08       Impact factor: 0.553

4.  Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.

Authors:  J C Stephens; D E Reich; D B Goldstein; H D Shin; M W Smith; M Carrington; C Winkler; G A Huttley; R Allikmets; L Schriml; B Gerrard; M Malasky; M D Ramos; S Morlot; M Tzetis; C Oddoux; F S di Giovine; G Nasioulas; D Chandler; M Aseev; M Hanson; L Kalaydjieva; D Glavac; P Gasparini; E Kanavakis; M Claustres; M Kambouris; H Ostrer; G Duff; V Baranov; H Sibul; A Metspalu; D Goldman; N Martin; D Duffy; J Schmidtke; X Estivill; S J O'Brien; M Dean
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

5.  Distribution of the CCR5 gene 32-bp deletion in Europe.

Authors:  G Lucotte; G Mercier
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-10-01

6.  HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group.

Authors:  I Theodorou; L Meyer; M Magierowska; C Katlama; C Rouzioux
Journal:  Lancet       Date:  1997-04-26       Impact factor: 79.321

7.  Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders.

Authors:  Y Lu; V R Nerurkar; W M Dashwood; C L Woodward; S Ablan; C M Shikuma; A Grandinetti; H Chang; H T Nguyen; Z Wu; Y Yamamura; W O Boto; A Merriwether; T Kurata; R Detels; R Yanagihara
Journal:  Int J Infect Dis       Date:  1999       Impact factor: 3.623

Review 8.  Molecular properties of the chemokine receptor family.

Authors:  R Horuk
Journal:  Trends Pharmacol Sci       Date:  1994-05       Impact factor: 14.819

Review 9.  MHC genes in autoimmunity.

Authors:  R D Campbell; C M Milner
Journal:  Curr Opin Immunol       Date:  1993-12       Impact factor: 7.486

Review 10.  An update of the HLA genomic region, locus information and disease associations: 2004.

Authors:  T Shiina; H Inoko; J K Kulski
Journal:  Tissue Antigens       Date:  2004-12
View more
  6 in total

1.  Polymorphism in chemokine receptor genes and risk of acute myocardial infarction in North Indian population.

Authors:  Neha Singh; Nakul Sinha; Sudeep Kumar; Chandra M Pandey; Suraksha Agrawal
Journal:  Mol Biol Rep       Date:  2011-07-10       Impact factor: 2.316

2.  Identification and frequency of CCR5Δ32/Δ32 HIV-resistant cord blood units from Houston area hospitals.

Authors:  G Gonzalez; Ss Park; Dw Chen; S Armitage; Ej Shpall; Rr Behringer
Journal:  HIV Med       Date:  2011-03-06       Impact factor: 3.180

3.  Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32.

Authors:  Timothy J Henrich; Emily Hanhauser; Zixin Hu; Hans-Jürgen Stellbrink; Christian Noah; Jeffrey N Martin; Steven G Deeks; Daniel R Kuritzkes; Florencia Pereyra
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177

4.  Association of Chemokine (C-C Motif) Receptor 5 and Ligand 5 with Recovery from Major Depressive Disorder and Related Neurocognitive Impairment.

Authors:  Olivia Bauer; Vladimir M Milenkovic; Sven Hilbert; Nina Sarubin; Johannes Weigl; Lisa-Marie Bahr; Thomas C Wetter; Barbara Heckel; Christian H Wetzel; Rainer Rupprecht; Caroline Nothdurfter
Journal:  Neuroimmunomodulation       Date:  2021-01-27       Impact factor: 2.492

Review 5.  Detection of CCR5Δ32 Mutant Alleles in Heterogeneous Cell Mixtures Using Droplet Digital PCR.

Authors:  Alyona Sorokina; Alexander Artyuhov; Alexandra Goltsova; Erdem Dashinimaev
Journal:  Front Mol Biosci       Date:  2022-02-21

6.  Absence of Association between CCR5 rs333 Polymorphism and Childhood Acute Lymphoblastic Leukemia.

Authors:  Carlos Eduardo Coral de Oliveira; Marla Karine Amarante; Aparecida de Lourdes Perim; Patricia Midori Murobushi Ozawa; Carlos Hiroki; Glauco Akelinghton Freire Vitiello; Roberta Losi Guembarovski; Maria Angelica Ehara Watanabe
Journal:  Adv Hematol       Date:  2014-04-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.